Journal Information
Vol. 14. Issue 5.
Pages 526-535 (September - October 2010)
Share
Share
Download PDF
More article options
Vol. 14. Issue 5.
Pages 526-535 (September - October 2010)
Review article
Open Access
Health surveillance, biosafety and emergence and re-emergence of infectious diseases in Brazil
Visits
2581
Telma Abdalla de Oliveira Cardoso1,
Corresponding author
abdalla@fiocruz.br

Correspondence to: Av. Brasil 4036, sala 716, Manguinhos, Rio de Janeiro, RJ, Brazil CEP: 21040-361 Phone/Fax: +55-21- 25905988.
, Marli B.M. de Albuquerque Navarro1, Cristina Costa Neto2, Josino Costa Moreira3
1 Researcher of Biosafety Office. National School of Public Health. Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
2 Researcher of Biologic Science Department. National School of Public Health. Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
3 Researher at the Center for Worker's Health and Human’ Ecology Studies. National School of Public Health. Oswaldo Cruz Foundation - Researher at the Center for Worker's Health and Human’ Ecology Studies. National School of Public Health. Oswaldo Cruz Foundation
This item has received

Under a Creative Commons license
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract

The present paper presents compulsory notification data for infectious diseases and epidemiologic ones recorded at the Center for Strategic Information and Health Surveillance (CIEVS) for the period of March 2006 to April 2007. Data is presented in accordance with geographic distribution, time and risk classification of the etiologic agents found, according to Ministry of Health regulations. The importance of this epidemiologic surveillance system is presented, debating the main topics required for quality improvement and information analysis. It is concluded, from the analysis of epidemiologic events and their relation to risk management, that the compulsory notification system in Brazil is incomplete, irregular, delayed and, in a large percentage of cases, notification cannot be completed and the agent may not be identified. Quality of data varies from one region to another and from county to county within the same region. There is a high proportion of cases in which the etiologic agent is unknown and, in such cases, a high lethality is expected, establishing a high risk exposure condition for those health professionals involved in health surveillance. From these data, the study points out the need to improve the surveillance system and strengthens the idea of building maximum containment laboratories.

Keywords:
biosafety
epidemiologic surveillance
infectious diseases
public health
Full text is only aviable in PDF
References
[1.]
T.A.O. Cardoso, M.B.M.A. Navarro.
Emerging and reemerging diseases in Brazil: data of a recent history of risks and uncertainties.
Braz J Infect Dis, 11 (2007), pp. 430-434
[2.]
M.B.M.A. Navarro, T.A.O. Cardoso.
Biossegurança e Ambiente: Complexidade e Instrumentalização.
Gaia Scientia, 1 (2007), pp. 107-114
[3.]
E.J.A. Luna.
The emergence of emerging diseases and emerging and re-emerging infectious diseases in Brazil.
Rev Bras Epidemiol, 5 (2002), pp. 229-243
[4.]
C.A. Possas.
Social ecosystem health: confronting the complexity and emergence of infectious diseases.
Cad Saúde Pública, 17 (2001), pp. 31-41
[5.]
M.B. Marques.
Emerging infectious diseases in the realm of complexity: implications for scientific and technological policies.
Cad Saúde Pública, 11 (1995), pp. 361-371
[6.]
R.A.C. Schmidt.
A questão ambiental na promoção da saúde: uma oportunidade de ação multiprofissional sobre doenças emergentes.
Physis, 17 (2007), pp. 373-392
[7.]
E.M. Hammann, J. Laguardia.
Reflexões sobre a vigilância epidemiológica: mais além da notificação compulsória.
Inf Epidemiol SUS, 9 (2000), pp. 211-219
[8.]
R. Franklin, Cockerill III, F.S. Thomas.
Response of the clinical microbiology laboratory to emerging (New) and re-emerging Infectious Diseases.
J Clin Microbiol, 42 (2004), pp. 2359-2365
[9.]
R.C.B. Barata.
The challenge of emergent disease and the return to descriptive epidemiology.
Rev Saúde Pública, 31 (1997), pp. 531-537
[10.]
E.H. Carmo, M.L. Barreto.
Mudanças nos padrões de morbimortalidade da população brasileira: os desafios para um novo século.
Epidemiologia e Serviços de Saúde, 12 (2003), pp. 63-75
[11.]
Rocha SS, Guerra C. A Biossegurança no Projeto de Qualidade do LACEN. LACEN-INLACEN 2000 Jan 4; p. 1.
[12.]
Cardoso TAO. Análise da construção da competência do Brasil em direção ao Laboratório de Contenção Máxima: realidades e perspectivas. Rio de Janeiro, 208p. Tese de (Doutorado) Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, 2008.
[13.]
Brasil. Ministério da Saúde. Portaria n° 5. Relação Nacional de Doenças de Notificação Compulsória; 2006.
[14.]
Centers for Disease Control and Prevention.
Principles of epidemiology. An introduction to applied epidemiology and biostatistics.
Centers for Disease Control and Prevention, (2006),
[15.]
Brasil. Ministério da Saúde. Comissão de Biossegurança em Saúde. Classificação dos Agentes Biológicos. Brasília, DF: Ministério da Saúde; 2006.
[16.]
B.E.C. Soares.
Biossegurança no Trabalho de Campo.
Biossegurança em Laboratório de Saúde Pública,
[17.]
E.A. Waldman.
Vigilância em Saúde Pública.
Faculdade de Saúde Pública da USP, (1998),
[18.]
J.A.I.A. Crane.
Emerging Challenges in Containment: development of a biodefense infrastructure.
Anthology of Biosafety VIII,
[19.]
National Institutes of Health. Final Report: 2005. Survey for determining the location, capacity, and status of existing and operating BSL3 laboratory facilities within the United States. [Online] http://www3.niaid.nih.gov/biodefense/PDF/BSL3_survey.pdf 2008.
[20.]
G.K. Gronvall, J. Fitzgerald, A. Chamberlain, A. Inglesby, T. O’Toole.
High-Containment Biodefense Research Laboratories: meeting report and center recommendations.
Biosecurity and Bioterrorism: biodefense strategy, practice, and science, 5 (2007), pp. 75-85
Copyright © 2010. Elsevier Editora Ltda.. All rights reserved
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools